• About
  • Subscribe
  • Advertise
  • Contact
Thursday, December 5, 2024
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Dr Andrew McAllister petitions Queensland policymakers over ophthalmology access in Darling Downs

by Myles Hume
August 29, 2023
in Local, News, Ophthalmic insights, Workforce
Reading Time: 4 mins read
A A
Dr Andrew McAllister, of Toowoomba Retina & Eye Specialists.

Dr Andrew McAllister, of Toowoomba Retina & Eye Specialists.

Share on FacebookShare on Twitter

Toowoomba’s Dr Andrew McAllister is behind a new petition calling for funding so that public ophthalmology patients in his local area can avoid the burden of travelling to Brisbane’s Princess Alexandra Hospital for treatment.

The petition was lodged on 8 August 2023 and calls on the Queensland Parliament to address the lack of medical and surgical treatment options for patients in the Darling Downs Health Service area for acute ophthalmology presentations via the private rooms of ophthalmologists in Toowoomba.

McAllister, of Toowoomba Retina & Eye Specialists, said currently there was no public hospital access for patients in Toowoomba and the Darling Downs, with patients transferred via ambulance or private transport to the closest tertiary hospital with ophthalmology registrars, Princess Alexandra Hospital.

This is despite there being six ophthalmologists in Toowoomba that have private practices. They have offered to see public patients, but McAllister said the hospital has repeatedly said that there is no funding to provide an ophthalmology service.

“We understand the cost pressures that the health service is under, which is why I would like to petition the state parliament for funding so patients who cannot afford treatment do not have to travel to Brisbane,” he told Insight.

“There is a travel and accommodation subsidy available for patients and their carers, who may need to spend days to weeks in Brisbane for emergency care and follow up. But why not put this funding towards patients staying within their local health district? Currently patients who cannot afford treatment are traveling out of the Darling Downs district for all ophthalmology treatment. What I am proposing is that funding be provided for patients that need acute medical care, which would include a consultation and surgery if needed.

“This, in turn, will take pressure off the local health service, reduce emergency presentations to the Princess Alexandra Hospital, the ambulance service, and reduce the time for patients and their carers to travel and stay away from their home and support networks. If funding can be provided for acute treatment, I would like to see chronic conditions that require long term treatment and management to be managed within our health district as well.”

McAllister said the common referrals that would normally require an urgent review would be medical and surgical causes of acute vision loss, trauma, and other conditions that are at risk of causing loss of vision, loss of an eye or death.

Requiring time-sensitive assessment, McAllister said this leads to treatment, and if a patient is unable to afford medical and surgical management via the private rooms they, need to be referred to the tertiary hospital.

“This is where funding is crucial so patients are able to have treatment locally, and we can offer the best possible care for our patients,” he said.

“The out-of-pocket costs for surgical and hospital admission can be several thousands of dollars if you are not privately insured, which is not rebatable through Medicare, and it is a difficult conversation to have with patients about this cost when they are their most vulnerable. If there is a funding stream available for acute ophthalmology services, patients then have the freedom of choice on where and when they have treatment locally.”

Potential solutions

McAllister said currently there are not the resources or funding available to establish an ophthalmology department at the local hospital. However, the private practices and day surgeries do have the resources and trained staff to be able to see patients with ophthalmology emergencies.

“What I would like to see is funding to be available from the local hospital to be able to have an urgent assessment and treatment in Toowoomba. Other specialties have this arrangement already in place, but this is because they have a presence at the public hospital already and so are funded,” he said.

“If a patient presents to the public hospital emergency department with loss of vision or a sight threatening condition, it would be great if the patient can be referred to and assessed by a local ophthalmologist rather than transport the patient to Brisbane. There is the ability for ophthalmologists to see patients with immediate access to care within the district, why not utilise it?”

More reading

Stop under-estimating healthcare isolation

Workforce: attracting more ophthalmologists to the regions

Ophthalmologist departs regional hospital with no obvious successor

Related Posts

A new WA clinic will give Aboriginal communities and others greater access to eyecare. Image: Sawoon/stock.adobe.com

New clinic will help address inequities in Aboriginal eyecare

by Staff Writer
December 5, 2024

A new eye clinic aims to make a significant impact in transforming eyecare for Aboriginal communities in Western Australia. A...

Or lack of it, depending on where you live, is the concern of the CPMC and others. Image: BJP7images/stock.adobe.com.

Health ministers warned that fast-track changes could bring ‘postcode’ health care

by Staff Writer
December 5, 2024

Australia’s state health ministers have been warned that the proposed fast-track registration of Specialist International Medical Graduates (SIMGs) risks exacerbating...

Alcon has confirmed its new Unity systems are now registered in Australia, and will be commercially available in 2025. Image: Konektus Photo/Shutterstock.com.

All-new Alcon Unity vitreoretinal and cataract systems approved in Australia

by Myles Hume
December 4, 2024

Alcon has revealed its “highly anticipated” Unity Vitreoretinal Cataract System and Unity Cataract System have been included on the Australian...

Join our newsletter

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited